FINWIRES · TerminalLIVE
FINWIRES

Goldman Sachs Adjusts Moderna Price Target to $43 From $41, Maintains Neutral Rating

By

Moderna (MRNA) has an average rating of Hold and mean price target of $45.21, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $55.38, Change: $+0.70, Percent Change: +1.28%

Related Articles